SCHEMBL7763213

SCHEMBL7763213

CCC(=O)NOC(=O)c1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ POLB P06746 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ PKM P14618 1/20 0.45
▸ MEN1 O00255 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ ERCC5 P28715 1/20 0.44
▸ FEN1 P39748 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ ADRB2 P07550 2/20 0.43
▸ ADRB1 P08588 2/20 0.43
▸ ADRB3 P13945 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9361076 0.84 KDM4E (0.50) KMT2ANPC1RAB9AALDH1A1L3MBTL1
SCHEMBL27894210 0.82 TSHR (0.53) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL29036935 0.81 CTSD (0.57) KMT2ANPC1RAB9AALDH1A1TSHR
SCHEMBL28034022 0.79 NPC1 (0.50) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL28770702 0.77 ALDH1A1 (0.61) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL27488418 0.77 MEN1 (0.49) KMT2ANPC1RAB9APOLBTSHR
SCHEMBL28748022 0.77 ALDH1A1 (0.66) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL27351517 0.76 HPGD (0.53) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL777261 0.76 NPC1 (0.53) KMT2ANPC1RAB9AL3MBTL1TSHR
SCHEMBL29436920 0.76 NPC1 (0.53) KMT2ANPC1RAB9AL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100510-A2 COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM Jomaa, Hassan (DE) 2001-05-23 — — EP disclosed
WO-1999066875-A2 COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM JOMAA HASSAN (DE) 1999-12-29 — — WO disclosed
Send feedback